News from the fight to
#SaveIndependentPharmacy
New York Times The Middlemen series
Drug middlemen in the hot seat: Q&A with USC Schaeffer Center’s Erin Trish
Constantly rising prescription drug prices appear to be driven in part by a little-understood group of firms called “pharmacy benefit managers.” USC Schaeffer Center research on the topic has the attention of the FTC and Congress, which has called executives to testify next week.
The biggest Pharmacy Benefit Managers (PBMs) are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.
The third in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs .